Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05293912
Title SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.
Indications

chronic lymphocytic leukemia

multiple myeloma

Hodgkin's lymphoma

non-Hodgkin lymphoma

Waldenstroem's macroglobulinemia

Therapies

SG2501

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.